NYSE:MO

Altria Group Inc (MO)

72.29
-0.70 (0.96%)
as of Jul 27, 2026, 2:00:46 pm Market Open.
62 watching
0
premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK
(A Top Pick Jun 22/21, Up 2.96%)Stockchase Research Editor: Michael O’Reilly Our PAST TOP PICK with MO is progressing well. We now recommend trailing up the stop (from $44) to $47.
premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK
(A Top Pick Jun 03/21, Up 1%)Stockchase Research Editor: Michael O'Reilly To ensure progressing capital returns of our PAST TOP PICK with MO, we recommend trailing the stop (from $40) to $44.
premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O'Reilly MO is a tobacco company, who pays an outstanding dividend that is backed by a payout ratio under 80%. It trades at 21x earnings, compared to peers at 61x. It continues to add to cash reserves, which are now estimated over $5 billion. Not a growth stock, but when combined with a strong dividend (that has increased for 12 consecutive years) it is good value here. We would buy this with a stop loss at $40, looking to achieve at least $53.50 -- although we favor trailing up the stop if that occurs. Yield 6.9% (Analysts’ price target is $53.45)
DON'T BUY
A good company he used to own. However, it suffers from a decline in tobacco consumption, and vaping is a serious challenge with low barriers to entry. He doesn't know when it will next outperform. Rising interest rates will be a negative, since their dividend will be less attractive. Just because this is cheap, doesn't mean the stock price will rise. Doesn't see cyclical upside here.
premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

BUY
Stockchase Research Editor: Michael O'Reilly We understand that many investors do not support companies that cater to our many vices. MO produces tobacco products and wine. However, it is an aristocrat with dividend growth -- it has increased it for 51 consecutive years -- and the yield is eye-opening. It released earnings today that beat analyst expectations. Sales and revenues were down slightly (about 2.5-5.0%), but the company stands by its EPS projections for the year. The company will begin a share buyback that is authorized up to $1 billion. Technically, we also like the re-test of $42.50 resistance, that if broken could see the stock re-visit pre-pandemic levels around $52 -- a potential 22% upside. Yield 7.9%
COMMENT
The sin stocks have always done extremely well with pricing even though the number of smokers has declined. If they continue to be able to raise price it will make up for the declining number of smokers. He doesn't own it because of ethics.
DON'T BUY
They made an investment in an acquisition that got them into cannabis. The company is best known for its dividend and he thinks it is safe. However, he cautions not to chase yield as the stock price has steadily fallen.
DON'T BUY
The regulatory environment is tough. He does not like to invest here. It is a secularly declining industry. The dividend yield does not make up for it. You could trade it.
COMMENT
There's 37% upside here. This has rolled over after a long run-up. He can't complain about MO. Pays a 6.5% yield and a good balance sheet. The only thing he doesn't like is its 5x price-to-book. But it's a solid grower.
COMMENT
He is not an expert on the tobacco companies, but sees them getting into cannabis as a smart move. He expects more tobacco companies to do the same. He does not know the company well enough to recommend a buy, but he is not interested.
DON'T BUY
They have entered into cannabis alongside tobacco and vaping. He has not invested to date as he stays away from such products. He likes how they have expanded into the emerging markets as well. In the long term, customers who die do not make good investors.
DON'T BUY

This tobacco company, falling into the consumer staples sector, is an area he is avoiding. As bond yields approach 3%, he feels bond proxy instruments (like high dividend yield tobacco) will get hit. The fact is, this stock trades relative to yield rates. He would direct you to real estate instead, if you are looking for yield.

BUY

A stock that is trading lower in an up market. If you look at the historical perspective, there is a clear support where there is strength. Trading at a good entry point.

Showing 16 to 30 of 141 entries